Overexpression of AT2R in the solitary-vagal complex improves baroreflex in the spontaneously hypertensive rat

Neuropeptides

Volumn 60, Issue , 2016, Pages 29-36

  Ruchaya, Prashant J ^a   Speretta, Guilherme F ^a   Blanch, Graziela Torres ^a   Li, Hongwei ^b   Sumners, Colin ^c   Menani, José V ^a   Colombari, Eduardo ^a   Colombari, Débora S A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

ACE2; Angiotensin II; Angiotensin receptor; Baroreflex; Hypertension; NTS

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; IN VIVO STUDY; MEAN ARTERIAL PRESSURE; MICROINJECTION; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TACHYCARDIA; TELEMETRY; VAGUS NERVE NUCLEUS; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BLOOD PRESSURE; GENETICS; HEART RATE; METABOLISM; SOLITARY TRACT NUCLEUS; VAGUS NERVE;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; HEART RATE; RATS; RATS, INBRED SHR; RECEPTOR, ANGIOTENSIN, TYPE 2; SOLITARY NUCLEUS; TELEMETRY; VAGUS NERVE;

EID: 84979780652     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2016.06.006     Document Type: Article

References (45)

1. Ali, Q., Wu, Y., Hussain, T., Chronic AT2 receptor activation attenuates renal AT1 receptor function and blood pressure in obese Zucker rats. Kidney Int. 84 (2013), 931–939.
2. Blanch, G.T., Freiria-Oliveira, A.H., Speretta, G.F., Carrera, E.J., Li, H., Speth, R.C., Colombari, E., Sumners, C., Colombari, D.S., Increased expression of angiotensin II type 2 receptors in the solitary-vagal complex blunts renovascular hypertension. Hypertension 64 (2014), 777–783.
3. Bosnyak, S., Welungoda, I.K., Hallberg, A., Alterman, M., Widdop, R.E., Jones, E.S., Stimulation of angiotensin AT2 receptors by the non-peptide agonist, compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br. J. Pharmacol. 159 (2010), 709–716.
4. Brouwers, S., Smolders, I., Massie, A., Dupont, A.G., Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo. Hypertension 62 (2013), 920–926.
5. Bruce, E., Shenoy, V., Rathinasabapathy, A., Espejo, A., Horowitz, A., Oswalt, A., Francis, J., Nair, A., Unger, T., Raizada, M.K., Steckelings, U.M., Sumners, C., Katovich, M.J., Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis. Br. J. Pharmacol. 172 (2015), 2219–2231.
6. Casto, R., Phillips, M.I., Mechanism of pressor effects by angiotensin in the nucleus tractus solitarius of rats. Am. J. Phys. 247 (1984), R575–R581.
7. Chappell, M.C., Pirro, N.T., Sykes, A., Ferrario, C.M., Metabolism of angiotensin-(1–7) by angiotensin-converting enzyme. Hypertension 31 (1998), 362–367.
8. Chaves, G.Z., Caligiorne, S.M., Santos, R.A., Khosla, M.C., Campagnole-Santos, M.J., Modulation of the baroreflex control of heart rate by angiotensin-(1–7) at the nucleus tractus solitarii of normotensive and spontaneously hypertensive rats. J. Hypertens. 18 (2000), 1841–1848.
9. de Kloet, A.D., Wang, L., Ludin, J.A., Smith, J.A., Pioquinto, D.J., Hiller, H., Steckelings, U.M., Scheuer, D.A., Sumners, C., Krause, E.G., Reporter mouse strain provides a novel look at angiotensin type-2 receptor distribution in the central nervous system. Brain Struct. Funct., 2014.
10. Diz, D.I., Garcia-Espinosa, M.A., Gegick, S., Tommasi, E.N., Ferrario, C.M., Ann Tallant, E., Chappell, M.C., Gallagher, P.E., Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats. Exp. Physiol. 93 (2008), 694–700.
11. Fisher, J.P., Fadel, P.J., Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension. Exp. Physiol. 95 (2010), 572–580.
12. Fraga-Silva, R.A., Ferreira, A.J., Dos Santos, R.A., Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1–7)/mas receptor pathway in hypertension. Curr. Hypertens. Rep. 15 (2013), 31–38.
13. Gao, L., Wang, W., Wang, W., Li, H., Sumners, C., Zucker, I.H., Effects of angiotensin type 2 receptor overexpression in the rostral ventrolateral medulla on blood pressure and urine excretion in normal rats. Hypertension 51 (2008), 521–527.
14. Grassi, G., Quarti-Trevano, F., Brambilla, G., Seravalle, G., Blood pressure control in resistant hypertension: new therapeutic options. Expert. Rev. Cardiovasc. Ther. 8 (2010), 1579–1585.
15. Guggilam, A., Patel, K.P., Haque, M., Ebenezer, P.J., Kapusta, D.R., Francis, J., Cytokine blockade attenuates sympathoexcitation in heart failure: cross-talk between nNOS, AT-1R and cytokines in the hypothalamic paraventricular nucleus. Eur. J. Heart Fail. 10 (2008), 625–634.
16. Guyenet, P.G., 2006. The sympathetic control of blood pressure. Nat.Rev. Neurosci. 7, 335–346.
17. Hein, L., Barsh, G.S., Pratt, R.E., Dzau, V.J., Kobilka, B.K., Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377 (1995), 744–747.
18. Ichiki, T., Labosky, P.A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B.L., Inagami, T., Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377 (1995), 748–750.
19. Ito, S., Komatsu, K., Tsukamoto, K., Kanmatsuse, K., Sved, A.F., Ventrolateral medulla AT1 receptors support blood pressure in hypertensive rats. Hypertension 40 (2002), 552–559.
20. Iwai, M., Horiuchi, M., Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens. Res. 32 (2009), 533–536.
21. Judy, W.V., Farrell, S.K., Arterial baroreceptor reflex control of sympathetic nerve activity in the spontaneously hypertensive rat. Hypertension 1 (1979), 605–614.
22. Kang, Y.M., Ma, Y., Elks, C., Zheng, J.P., Yang, Z.M., Francis, J., Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kappaB. Cardiovasc. Res. 79 (2008), 671–678.
23. La Rovere, M.T., Bigger, J.T. Jr., Marcus, F.I., Mortara, A., Schwartz, P.J., Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) investigators. Lancet 351 (1998), 478–484.
24. La Rovere, M.T., Pinna, G.D., Maestri, R., Sleight, P., Clinical value of baroreflex sensitivity. Neth. Hear. J. 21 (2013), 61–63.
25. Li, Z., Iwai, M., Wu, L., Shiuchi, T., Jinno, T., Cui, T.X., Horiuchi, M., Role of AT2 receptor in the brain in regulation of blood pressure and water intake. Am. J. Physiol. Heart Circ. Physiol. 284 (2003), H116–H121.
26. Li, H.W., Gao, Y.X., Raizada, M.K., Sumners, C., Intronic enhancement of angiotensin II type 2 receptor transgene expression in vitro and in vivo. Biochem. Biophys. Res. Commun. 336 (2005), 29–35.
27. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001), 402–408.
28. Mann, S.J., Neurogenic essential hypertension revisited: the case for increased clinical and research attention. Am. J. Hypertens. 16 (2003), 881–888.
29. Matavelli, L.C., Huang, J., Siragy, H.M., Angiotensin AT2 receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension 57 (2011), 308–313.
30. Mayorov, D.N., Head, G.A., De, M.R., Tempol attenuates excitatory actions of angiotensin II in the rostral ventrolateral medulla during emotional stress. Hypertension 44 (2004), 101–106.
31. Moreira, T.S., Takakura, A.C., Colombari, E., Menani, J.V., Antihypertensive effects of central ablations in spontaneously hypertensive rats. Am.J.Physiol Regul.Integr.Comp. Physiol. 296 (2009), R1797–R1806.
32. Mukoyama, M., Nakajima, M., Horiuchi, M., Sasamura, H., Pratt, R.E., Dzau, V.J., Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J. Biol. Chem. 268 (1993), 24539–24542.
33. Paxinos, G., Watson, C., The Rat Brain in Stereotaxic Coordinates. second ed., 1986, Academic Press, Inc, San Diego.
34. Primatesta, P., Poulter, N.R., Improvement in hypertension management in England: results from the Health Survey for England 2003. J. Hypertens. 24 (2006), 1187–1192.
35. Rettig, R., Healy, D.P., Printz, M.P., Cardiovascular effects of microinjections of angiotensin II into the nucleus tractus solitarii. Brain Res. 364 (1986), 233–240.
36. Sato, M.A., Menani, J.V., Lopes, O.U., Colombari, E., Lesions of the commissural nucleus of the solitary tract reduce arterial pressure in spontaneously hypertensive rats. Hypertension 38 (2001), 560–564.
37. Shi, P., Diez-Freire, C., Jun, J.Y., Qi, Y., Katovich, M.J., Li, Q., Sriramula, S., Francis, J., Sumners, C., Raizada, M.K., Brain microglial cytokines in neurogenic hypertension. Hypertension 56 (2010), 297–303.
38. Sriramula, S., Cardinale, J.P., Francis, J., Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension. PLoS·One, 8, 2013, e63847.
39. Takagishi, M., Waki, H., Bhuiyan, M.E., Gouraud, S.S., Kohsaka, A., Cui, H., Yamazaki, T., Paton, J.F., Maeda, M., IL-6 microinjected in the nucleus tractus solitarii attenuates cardiac baroreceptor reflex function in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298 (2010), R183–R190.
40. Trippodo, N.C., Frohlich, E.D., Similarities of genetic (spontaneous) hypertension. Man and rat. Circ. Res. 48 (1981), 309–319.
41. Veerasingham, S.J., Raizada, M.K., Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br. J. Pharmacol. 139 (2003), 191–202.
42. Yamazato, Y., Ferreira, A.J., Hong, K.H., Sriramula, S., Francis, J., Yamazato, M., Yuan, L., Bradford, C.N., Shenoy, V., Oh, S.P., Katovich, M.J., Raizada, M.K., Prevention of pulmonary hypertension by angiotensin-converting enzyme 2 gene transfer. Hypertension 54 (2009), 365–371.
43. Yamazato, M., Ferreira, A.J., Yamazato, Y., Diez-Freire, C., Yuan, L., Gillies, R., Raizada, M.K., Gene transfer of angiotensin-converting enzyme 2 in the nucleus tractus solitarius improves baroreceptor heart rate reflex in spontaneously hypertensive rats. J. Renin-Angiotensin-Aldosterone Syst. 12 (2011), 456–461.
44. Zhang, Y., Gao, Y., Speth, R.C., Jiang, N., Mao, Y., Sumners, C., Li, H., Adenoviral and adeno-associated viral vectors-mediated neuronal gene transfer to cardiovascular control regions of the rat brain. Int. J. Med. Sci. 10 (2013), 607–616.
45. Zhu, G.Q., Patel, K.P., Zucker, I.H., Wang, W., Microinjection of ANG II into paraventricular nucleus enhances cardiac sympathetic afferent reflex in rats. Am. J. Physiol. Heart Circ. Physiol. 282 (2002), H2039–H2045.